Profiling neuroinflammatory markers and response to nusinersen in paediatric spinal muscular atrophy.

Interestingly, a marginally significant correlation ( P = 0.0535) was observed in SMA1 patients between the baseline IL-10 levels and changes in motor scores after 6 months of nusinersen treatment (Fig. 3 G).

also in 26,082 other papers